{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:58:16Z","timestamp":1794956296149,"version":"4.9.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,3]],"date-time":"2018-03-03T00:00:00Z","timestamp":1520035200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s12185-018-2430-6","type":"journal-article","created":{"date-parts":[[2018,3,3]],"date-time":"2018-03-03T03:17:01Z","timestamp":1520047021000},"page":"420-427","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Epidemiology of malignant lymphoma and recent progress in research on adult T-cell leukemia\/lymphoma in Japan"],"prefix":"10.1007","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2356-3725","authenticated-orcid":false,"given":"Hiroaki","family":"Miyoshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,3]]},"reference":[{"key":"2430_CR1","unstructured":"National Cancer Cancer Center,  Center for Cancer Control and Information Services. \n                    https:\/\/ganjoho.jp\/reg_stat\/statistics\/stat\/summary.html\n                    \n                  . Accessed 24 Dec 2017."},{"key":"2430_CR2","first-page":"16","volume-title":"The global and regional burden of Cancer. World Cancer Report (Stewart EW, Wild CP, edited)","author":"D Forman","year":"2014","unstructured":"Forman D, Ferlay J. The global and regional burden of Cancer. World Cancer Report (Stewart EW, Wild CP, edited). Lyon: International Agency for Research on Cancer; 2014. p. 16\u201353."},{"key":"2430_CR3","first-page":"482","volume-title":"Haematopoietic and lymphoid malignancies. World Cancer Report (Stewart EW, Wild CP, edited)","author":"ES Jaffe","year":"2014","unstructured":"Jaffe ES, Swerdlow SH, Vardiman JW. Haematopoietic and lymphoid malignancies. World Cancer Report (Stewart EW, Wild CP, edited). Lyon: International Agency for Research on Cancer; 2014. p. 482\u201394."},{"key":"2430_CR4","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1440-1827.2007.02207.x","volume":"58","author":"R Aoki","year":"2008","unstructured":"Aoki R, Karube K, Sugita Y, Nomura Y, Shimizu K, Kimura Y, et al. Distribution of malignant lymphoma in Japan: analysis of 2260 cases, 2001\u20132006. Pathol Int. 2008;58:174\u201382.","journal-title":"Pathol Int"},{"key":"2430_CR5","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1046\/j.1440-1827.2000.01108.x","volume":"50","author":"Lymphoma Study Group of Japanese Pathologists","year":"2000","unstructured":"Lymphoma Study Group of Japanese Pathologists. The world health organization classification of malignant lymphomas in japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists. Pathol Int. 2000;50:696\u2013702.","journal-title":"Pathol Int"},{"key":"2430_CR6","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/ijc.29477","volume":"137","author":"D Chihara","year":"2015","unstructured":"Chihara D, Ito H, Izutsu K, Hattori M, Nishino Y, Ioka A, et al. Advance and stagnation in the treatment of patients with lymphoma and myeloma: analysis using population-based cancer registry data in Japan from 1993 to 2006. Int J Cancer. 2015;137:1217\u201323.","journal-title":"Int J Cancer"},{"key":"2430_CR7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1309\/AJCP7YLTQPUSDQ5C","volume":"138","author":"J Sun","year":"2012","unstructured":"Sun J, Yang Q, Lu Z, He M, Gao L, Zhu M, et al. Distribution of lymphoid neoplasms in China: analysis of 4638 cases according to the World Health Organization classification. Am J Clin Pathol. 2012;138:429\u201334.","journal-title":"Am J Clin Pathol"},{"key":"2430_CR8","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/ajh.21824","volume":"85","author":"SO Yoon","year":"2010","unstructured":"Yoon SO, Suh C, Lee DH, Chi HS, Park CJ, Jang SS, et al. Distribution of lymphoid neoplasms in the Republic of Korea: analysis of 5318 cases according to the World Health Organization classification. Am J Hematol. 2010;85:760\u20134.","journal-title":"Am J Hematol"},{"key":"2430_CR9","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1182\/blood-2015-03-632489","volume":"126","author":"H Katsuya","year":"2015","unstructured":"Katsuya H, Ishitsuka K, Utsunomiya A, Hanada S, Eto T, Moriuchi Y, et al. Treatment and survival among 1594 patients with ATL. Blood. 2015;126:2570\u20137.","journal-title":"Blood"},{"key":"2430_CR10","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1182\/blood-2009-10-247510","volume":"116","author":"M Hishizawa","year":"2010","unstructured":"Hishizawa M, Kanda J, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y, et al. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood. 2010;116:1369\u201376.","journal-title":"Blood"},{"key":"2430_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1182\/blood-2017-01-757542","volume":"130","author":"H Katsuya","year":"2017","unstructured":"Katsuya H, Shimokawa M, Ishitsuka K, Kawai K, Amano M, Utsunomiya A, et al. Prognostic index for chronic- and smoldering-type adult T-cell leukemia-lymphoma. Blood. 2017;130:39\u201347.","journal-title":"Blood"},{"key":"2430_CR12","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","volume":"79","author":"M Shimoyama","year":"1991","unstructured":"Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984\u201387). Br J Haematol. 1991;79:428\u201337.","journal-title":"Br J Haematol"},{"key":"2430_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1182\/blood-2017-01-761874","volume":"131","author":"K Kataoka","year":"2018","unstructured":"Kataoka K, Iwanaga M, Yasunaga JI, Nagata Y, Kitanaka A, Kameda T, et al. Prognostic relevance of integrated genetic profiling in adult T-cell leukemia\/lymphoma. Blood. 2018;131:215\u201325.","journal-title":"Blood"},{"key":"2430_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/ng.2872","volume":"46","author":"M Sakata-Yanagimoto","year":"2014","unstructured":"Sakata-Yanagimoto M, Enami T, Yoshida K, Shiraishi Y, Ishii R, Miyake Y, et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet. 2014;46:171\u20135.","journal-title":"Nat Genet"},{"key":"2430_CR15","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1182\/blood-2015-06-644948","volume":"127","author":"Y Nagata","year":"2016","unstructured":"Nagata Y, Kontani K, Enami T, Kataoka K, Ishii R, Totoki Y, et al. Variegated RHOA mutations in adult T-cell leukemia\/lymphoma. Blood. 2016;127:596\u2013604.","journal-title":"Blood"},{"key":"2430_CR16","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","volume":"25","author":"K Tsukasaki","year":"2007","unstructured":"Tsukasaki K, Utsunomiya A, Fukuda H, Shibata T, Fukushima T, Takatsuka Y, et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol. 2007;25:5458\u201364.","journal-title":"J Clin Oncol"},{"key":"2430_CR17","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1200\/JCO.2016.67.7732","volume":"34","author":"T Ishida","year":"2016","unstructured":"Ishida T, Fujiwara H, Nosaka K, Taira N, Abe Y, Imaizumi Y, et al. Multicenter phase II study of lenalidomide in relapsed or recurrent adult T-Cell leukemia\/lymphoma. J Clin Oncol. 2016;34:4086\u201393.","journal-title":"J Clin Oncol"},{"key":"2430_CR18","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1182\/blood-2016-09-741983","volume":"130","author":"T Narita","year":"2017","unstructured":"Narita T, Ishida T, Ito A, Masaki A, Kinoshita S, Suzuki S, et al. Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia\/lymphoma. Blood. 2017;130:1114\u201324.","journal-title":"Blood"},{"key":"2430_CR19","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1182\/blood-2015-02-629600","volume":"126","author":"J Kiyasu","year":"2015","unstructured":"Kiyasu J, Miyoshi H, Hirata A, Arakawa F, Ichikawa A, Niino D, et al. Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma. Blood. 2015;126:2193\u2013201.","journal-title":"Blood"},{"key":"2430_CR20","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.athoracsur.2015.10.044","volume":"101","author":"S Yokoyama","year":"2016","unstructured":"Yokoyama S, Miyoshi H, Nishi T, Hashiguchi T, Mitsuoka M, Takamori S, et al. Clinicopathologic and prognostic implications of programmed death ligand 1 expression in thymoma. Ann Thorac Surg. 2016;101:1361\u20139.","journal-title":"Ann Thorac Surg"},{"key":"2430_CR21","doi-asserted-by":"publisher","first-page":"4727","DOI":"10.1158\/1078-0432.CCR-16-0434","volume":"22","author":"S Yokoyama","year":"2016","unstructured":"Yokoyama S, Miyoshi H, Nakashima K, Shimono J, Hashiguchi T, Mitsuoka M, et al. Prognostic value of programmed death ligand 1 and programmed death 1 expression in thymic carcinoma. Clin Cancer Res. 2016;22:4727\u201334.","journal-title":"Clin Cancer Res"},{"key":"2430_CR22","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1182\/blood-2016-02-698936","volume":"128","author":"H Miyoshi","year":"2016","unstructured":"Miyoshi H, Kiyasu J, Kato T, Yoshida N, Shimono J, Yokoyama S, et al. PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia\/lymphoma. Blood. 2016;128:1374\u201381.","journal-title":"Blood"},{"key":"2430_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/his.13461","author":"N Asano","year":"2018","unstructured":"Asano N, Miyoshi H, Kato T, Shimono J, Yoshida N, Kurita D, et al. Expression pattern of immunosurveillance-related antigen in adult T-cell leukemia\/lymphoma. Histopathology. 2018. \n                    https:\/\/doi.org\/10.1111\/his.13461\n                    \n                   (Epub ahead of print)","journal-title":"Histopathology"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-018-2430-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-018-2430-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-018-2430-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,2]],"date-time":"2019-03-02T19:40:23Z","timestamp":1551555623000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-018-2430-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,3]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["2430"],"URL":"https:\/\/doi.org\/10.1007\/s12185-018-2430-6","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,3]]},"assertion":[{"value":"13 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There is no conflict of interest to be declared in this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}